BRISTOL-MYERS SQUIBB COMPANY Acquisitions, Net of Cash Acquired
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Acquisitions, Net of Cash Acquired of $156.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY payments to acquire businesses, net of cash acquired for the quarter ending 2026-06-30 was $91.00M, a 68.07% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY payments to acquire businesses, net of cash acquired for the quarter ending 2026-03-31 was $65.00M, a 16.67% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-31 was $1.71B, a 3531.91% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-30 was $1.87B, a 438.51% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY payments to acquire businesses, net of cash acquired for fiscal 2025 was $3.94B, a 81.93% decline from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY payments to acquire businesses, net of cash acquired for fiscal 2024 was $21.82B, a 1766.64% increase from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY payments to acquire businesses, net of cash acquired for fiscal 2023 was $1.17B, a 72.73% decline from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY payments to acquire businesses, net of cash acquired for fiscal 2022 was $4.29B, a 166.21% increase from fiscal 2021.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 3 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $91.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $156.00M 10-Q · filed 2026-07-30 | $1.86B derived: sum of 3 quarters · filed 2026-07-30 | $3.74B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $65.00M 10-Q · filed 2026-04-30 | $1.77B derived: sum of 2 quarters · filed 2026-04-30 | $3.65B derived: sum of 3 quarters · filed 2026-04-30 | $3.93B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $1.71B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $3.58B derived: sum of 2 quarters · filed 2026-02-11 | $3.87B derived: sum of 3 quarters · filed 2026-07-30 | $3.94B 10-K · filed 2026-02-11 | ||||
| 2025-09-30 | $1.87B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.16B derived: sum of 2 quarters · filed 2026-07-30 | $2.24B 10-Q · filed 2025-10-30 | $2.28B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $285.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $363.00M 10-Q · filed 2026-07-30 | $410.00M derived: sum of 3 quarters · filed 2026-07-30 | $758.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $78.00M 10-Q · filed 2026-04-30 | $125.00M derived: sum of 2 quarters · filed 2026-04-30 | $473.00M derived: sum of 3 quarters · filed 2026-04-30 | $1.85B derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $395.00M derived: sum of 2 quarters · filed 2026-02-11 | $1.77B derived: sum of 3 quarters · filed 2026-02-11 | $21.82B 10-K · filed 2026-02-11 | ||||
| 2024-09-30 | $348.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.72B derived: sum of 2 quarters · filed 2025-10-30 | $21.77B 10-Q · filed 2025-10-30 | $22.36B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | $1.37B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $21.43B 10-Q · filed 2025-07-31 | $22.01B derived: sum of 3 quarters · filed 2026-02-11 | $22.33B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | $20.05B 10-Q · filed 2025-04-24 | $20.63B derived: sum of 2 quarters · filed 2026-02-11 | $20.96B derived: sum of 3 quarters · filed 2026-02-11 | $21.14B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $581.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $907.00M derived: sum of 2 quarters · filed 2026-02-11 | $1.09B derived: sum of 3 quarters · filed 2026-02-11 | $1.17B 10-K · filed 2026-02-11 | ||||
| 2023-09-30 | $326.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $510.00M derived: sum of 2 quarters · filed 2024-10-31 | $588.00M 10-Q · filed 2024-10-31 | $704.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $184.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $262.00M 10-Q · filed 2024-07-26 | $378.00M derived: sum of 3 quarters · filed 2025-02-12 | $3.64B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $78.00M 10-Q · filed 2024-04-25 | $194.00M derived: sum of 2 quarters · filed 2025-02-12 | $3.46B derived: sum of 3 quarters · filed 2025-02-12 | $3.92B derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $116.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $3.38B derived: sum of 2 quarters · filed 2025-02-12 | $3.84B derived: sum of 3 quarters · filed 2025-02-12 | $4.29B 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $3.26B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $3.73B derived: sum of 2 quarters · filed 2023-10-26 | $4.17B 10-Q · filed 2023-10-26 | $4.32B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-06-30 | $467.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $909.00M 10-Q · filed 2023-07-27 | $1.06B derived: sum of 3 quarters · filed 2024-02-13 | $2.12B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-03-31 | $442.00M 10-Q · filed 2023-04-27 | $594.00M derived: sum of 2 quarters · filed 2024-02-13 | $1.65B derived: sum of 3 quarters · filed 2024-02-13 | $2.02B derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2021-12-31 | $152.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $1.21B derived: sum of 2 quarters · filed 2024-02-13 | $1.57B derived: sum of 3 quarters · filed 2024-02-13 | $1.61B 10-K · filed 2024-02-13 | ||||
| 2021-09-30 | $1.06B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $1.42B derived: sum of 2 quarters · filed 2022-10-26 | $1.46B 10-Q · filed 2022-10-26 | $13.81B derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-06-30 | $366.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $401.00M 10-Q · filed 2022-07-27 | $12.75B derived: sum of 3 quarters · filed 2023-02-14 | $13.04B derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2021-03-31 | $35.00M 10-Q · filed 2022-04-29 | $12.38B derived: sum of 2 quarters · filed 2023-02-14 | $12.67B derived: sum of 3 quarters · filed 2023-02-14 | $13.05B derived: sum of 4 quarters · filed 2023-02-14 | ||||
| 2020-12-31 | $12.35B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $12.64B derived: sum of 2 quarters · filed 2023-02-14 | $13.02B derived: sum of 3 quarters · filed 2023-02-14 | $13.08B 10-K · filed 2023-02-14 | ||||
| 2020-09-30 | $291.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $668.00M derived: sum of 2 quarters · filed 2021-10-27 | $736.00M 10-Q · filed 2021-10-27 | $421.00M 10-Q · filed 2020-11-05 | $25.45B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-06-30 | $377.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $445.00M 10-Q · filed 2021-07-28 | $178.00M 10-Q · filed 2020-08-06 | $25.16B derived: sum of 3 quarters · filed 2022-02-09 | $25.17B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-03-31 | $68.00M 10-Q · filed 2021-04-29 | $25.00M 10-Q · filed 2020-05-07 | $24.79B derived: sum of 2 quarters · filed 2022-02-09 | $24.80B derived: sum of 3 quarters · filed 2022-02-09 | $24.83B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2019-12-31 | $24.72B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $24.73B derived: sum of 2 quarters · filed 2022-02-09 | $24.76B derived: sum of 3 quarters · filed 2022-02-09 | $24.78B 10-K · filed 2022-02-09 | $24.63B 10-K · filed 2020-02-24 | |||
| 2019-09-30 | $9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $43.00M derived: sum of 2 quarters · filed 2020-11-05 | $58.00M 10-Q · filed 2020-11-05 | $1.22B derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-06-30 | $34.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $49.00M 10-Q · filed 2020-08-06 | $1.21B derived: sum of 3 quarters · filed 2021-02-10 | $1.25B derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-03-31 | $15.00M 10-Q · filed 2020-05-07 | $1.17B derived: sum of 2 quarters · filed 2021-02-10 | $1.22B derived: sum of 3 quarters · filed 2021-02-10 | $2.05B derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2018-12-31 | $1.16B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $1.20B derived: sum of 2 quarters · filed 2021-02-10 | $2.04B derived: sum of 3 quarters · filed 2021-02-10 | $2.37B 10-K · filed 2021-02-10 | $1.25B 10-K · filed 2019-02-25 | |||
| 2018-09-30 | $45.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $879.00M derived: sum of 2 quarters · filed 2019-10-31 | $1.22B 10-Q · filed 2019-10-31 | $1.27B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $834.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $1.17B 10-Q · filed 2019-07-25 | $1.22B derived: sum of 3 quarters · filed 2020-02-24 | $1.58B derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $336.00M 10-Q · filed 2019-04-25 | $390.00M derived: sum of 2 quarters · filed 2020-02-24 | $743.00M derived: sum of 3 quarters · filed 2020-02-24 | $950.00M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $54.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $407.00M derived: sum of 2 quarters · filed 2020-02-24 | $614.00M derived: sum of 3 quarters · filed 2020-02-24 | $726.00M 10-K · filed 2020-02-24 | $708.00M 10-K · filed 2018-02-13 | |||
| 2017-09-30 | $353.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $560.00M derived: sum of 2 quarters · filed 2018-10-25 | $672.00M 10-Q · filed 2018-10-25 | $720.00M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $207.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $319.00M 10-Q · filed 2018-07-26 | $367.00M derived: sum of 3 quarters · filed 2019-02-25 | $411.00M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $112.00M 10-Q · filed 2018-04-26 | $160.00M derived: sum of 2 quarters · filed 2019-02-25 | $204.00M derived: sum of 3 quarters · filed 2019-02-25 | $463.00M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $48.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $92.00M derived: sum of 2 quarters · filed 2019-02-25 | $351.00M derived: sum of 3 quarters · filed 2019-02-25 | $359.00M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $303.00M derived: sum of 2 quarters · filed 2017-10-26 | $311.00M 10-Q · filed 2017-10-26 | $530.00M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-06-30 | $259.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $267.00M 10-Q · filed 2017-07-27 | $486.00M derived: sum of 3 quarters · filed 2018-02-13 | $523.00M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-03-31 | $8.00M 10-Q · filed 2017-04-27 | $227.00M derived: sum of 2 quarters · filed 2018-02-13 | $264.00M derived: sum of 3 quarters · filed 2018-02-13 | |||||
| 2015-12-31 | $219.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $256.00M derived: sum of 2 quarters · filed 2018-02-13 | $1.11B 10-K · filed 2018-02-13 | |||||
| 2015-09-30 | $37.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $892.00M 10-Q · filed 2016-10-27 | ||||||
| 2015-06-30 | $855.00M 10-Q · filed 2016-07-28 | |||||||
| 2014-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $6.00M derived: sum of 2 quarters · filed 2017-02-21 | $198.00M derived: sum of 3 quarters · filed 2017-02-21 | $219.00M 10-K · filed 2017-02-21 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $192.00M derived: sum of 2 quarters · filed 2015-10-27 | $213.00M 10-Q · filed 2015-10-27 | |||||
| 2014-06-30 | $192.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $213.00M 10-Q · filed 2015-07-23 | ||||||
| 2014-03-31 | $21.00M 10-Q · filed 2015-04-28 | |||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $5.04B derived: sum of 2 quarters · filed 2015-02-13 | $5.04B derived: sum of 3 quarters · filed 2015-02-13 | $7.53B 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | $5.04B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $5.04B derived: sum of 2 quarters · filed 2013-10-23 | $7.53B 10-Q · filed 2013-10-23 | $7.58B derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $2.49B 10-Q · filed 2013-07-25 | $2.54B derived: sum of 3 quarters · filed 2014-02-14 | |||||
| 2012-03-31 | $2.49B 10-Q · filed 2013-04-25 | $2.54B derived: sum of 2 quarters · filed 2014-02-14 | ||||||
| 2011-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $360.00M 10-K · filed 2014-02-14 | ||||||
| 2011-09-30 | $310.00M 10-Q · filed 2012-10-24 | |||||||
| 2010-12-31 | $829.00M 10-K · filed 2013-02-15 | |||||||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $2.23B derived: sum of 2 quarters · filed 2012-02-17 | $2.23B 10-K · filed 2012-02-17 | |||||
| 2009-09-30 | $2.23B derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $2.23B 10-Q · filed 2010-10-26 | ||||||
| 2009-06-30 | $0.00 10-Q · filed 2009-07-23 | |||||||
| 2008-12-31 | $191.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $0.00 derived: sum of 2 quarters · filed 2011-02-18 | $191.00M 10-K · filed 2011-02-18 | |||||
| 2008-09-30 | -$191.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $0.00 10-Q · filed 2009-10-22 | ||||||
| 2008-06-30 | $191.00M 10-Q · filed 2009-07-23 | |||||||
| 2007-12-31 | $432.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |